Want to see EVH full AI Analyst Report?
Total Valuation
Evolent Health has a market cap or net worth of $463.54M. The enterprise value is $1.44K.
Market Cap$463.54M
Enterprise Value$1.44K
Share Statistics
Evolent Health has 113,059,330 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding113,059,330
Owned by Insiders2.82%
Owned by Institutions3.63%
Financial Efficiency
Evolent Health’s return on equity (ROE) is -1.29 and return on invested capital (ROIC) is -0.29%.
Return on Equity (ROE)-1.29
Return on Assets (ROA)-0.28
Return on Invested Capital (ROIC)-0.29%
Return on Capital Employed (ROCE)>-0.01
Revenue Per Employee446.72K
Profits Per Employee-137.95K
Employee Count4,200
Asset Turnover0.99
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Evolent Health is ―. Evolent Health’s PEG ratio is -0.00150.
PE Ratio―
PS Ratio0.24
PB Ratio1.10
Price to Fair Value1.10
Price to FCF96.07
Price to Operating Cash Flow8.80
PEG Ratio-0.00150
Income Statement
In the last 12 months, Evolent Health had revenue of 1.88B and earned -534.51M in profits. Earnings per share was -5.07.
Revenue1.88B
Gross Profit284.03M
Operating Income-4.43M
Pretax Income-534.64M
Net Income-534.51M
EBITDA-361.31M
Earnings Per Share (EPS)-5.07
Cash Flow
In the last 12 months, operating cash flow was 53.33M and capital expenditures -36.38M, giving a free cash flow of 16.95M billion.
Operating Cash Flow53.33M
Free Cash Flow16.95M
Free Cash Flow per Share0.15
Dividends & Yields
Evolent Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.59
52-Week Price Change-52.72%
50-Day Moving Average4.72
200-Day Moving Average3.97
Relative Strength Index (RSI)48.52
Average Volume (3m)2.67M
Important Dates
Evolent Health upcoming earnings date is Nov 4, 2026, After Close (Confirmed).
Last Earnings DateAug 6, 2026
Next Earnings DateNov 4, 2026
Ex-Dividend Date―
Financial Position
Evolent Health as a current ratio of 1.31, with Debt / Equity ratio of 253.23%
Current Ratio1.31
Quick Ratio1.31
Debt to Market Cap2.12
Net Debt to EBITDA-2.32
Interest Coverage Ratio-0.08
Taxes
In the past 12 months, Evolent Health has paid -126.00K in taxes.
Income Tax-126.00K
Effective Tax Rate<0.01
Enterprise Valuation
Evolent Health EV to EBITDA ratio is -3.58, with an EV/FCF ratio of 272.28.
EV to Sales0.69
EV to EBITDA-3.58
EV to Free Cash Flow272.28
EV to Operating Cash Flow33.33
Balance Sheet
Evolent Health has $115.70M in cash and marketable securities with $970.43M in debt, giving a net cash position of -$854.73M billion.
Cash & Marketable Securities$115.70M
Total Debt$970.43M
Net Cash-$854.73M
Net Cash Per Share-$7.56
Tangible Book Value Per Share-$7.57
Margins
Gross margin is 12.92%, with operating margin of -0.24%, and net profit margin of -28.49%.
Gross Margin12.92%
Operating Margin-0.24%
Pretax Margin-28.50%
Net Profit Margin-28.49%
EBITDA Margin-19.26%
EBIT Margin-25.43%
Analyst Forecast
The average price target for Evolent Health is $5.67, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$5.67
Price Target Upside34.28% Upside
Analyst ConsensusModerate Buy
Analyst Count11
Revenue Growth Forecast-4.50%
EPS Growth Forecast-184.71%